Antoine Dufour Selected Research

3C Viral Proteases

1/2018

N-Terminomics TAILS Identifies Host Cell Substrates of Poliovirus and Coxsackievirus B3 3C Proteinases That Modulate Virus Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antoine Dufour Research Topics

Disease

12	Inflammation (Inflammations) 01/2022 - 02/2012
10	Neoplasms (Cancer) 01/2022 - 11/2008
4	Virus Diseases (Viral Diseases) 12/2021 - 07/2015
4	Neoplasm Metastasis (Metastasis) 08/2019 - 07/2011
3	Disease Progression 01/2022 - 12/2020
2	Demyelinating Diseases (Demyelinating Disease) 01/2021 - 01/2021
2	Infections 01/2018 - 07/2015
1	Pre-Eclampsia (Preeclampsia) 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Animal Disease Models 01/2022
1	Fibrosis (Cirrhosis) 01/2022
1	COVID-19 01/2022
1	Pain (Aches) 02/2021
1	Neuroinflammatory Diseases 01/2021
1	Amebiasis (Amoebiasis) 01/2021
1	Crohn Disease (Crohn's Disease) 01/2021
1	Dry Eye Syndromes (Dry Eye Syndrome) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2020
1	Reperfusion Injury 11/2019
1	Ulcerative Colitis 11/2019
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2018
1	Pathologic Processes 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 11/2015
1	Enterovirus Infections 07/2015
1	Picornaviridae Infections 07/2015
1	Peritonitis 10/2014
1	Multiple Sclerosis 04/2012
1	Colonic Neoplasms (Colon Cancer) 01/2009

Drug/Important Bio-Agent (IBA)

10	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 07/2011
9	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 04/2012
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2013
3	Matrix Metalloproteinase InhibitorsIBA 01/2022 - 07/2011
3	Biological ProductsIBA 12/2021 - 11/2008
3	AminesIBA 11/2019 - 10/2014
3	Pharmaceutical PreparationsIBA 04/2013 - 01/2009
2	CollagenIBA 01/2022 - 04/2013
2	Proteoglycans (Proteoglycan)IBA 01/2021 - 01/2019
2	ChemokinesIBA 01/2021 - 02/2012
2	LubricantsIBA 01/2021 - 01/2019
2	CytokinesIBA 01/2021 - 01/2021
2	MucinsIBA 01/2021 - 12/2018
2	Antiviral Agents (Antivirals)IBA 01/2018 - 07/2015
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Trypsin InhibitorsIBA 01/2022
1	InterferonsIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	Fibrinogen (Factor I)FDA Link 01/2022
1	Fibronectins (Fibronectin)IBA 01/2022
1	ProstaglandinsIBA 01/2022
1	CationsIBA 02/2021
1	ProteomeIBA 01/2021
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	Glycoproteins (Glycoprotein)IBA 01/2021
1	Heparin (Liquaemin)FDA LinkGeneric 01/2021
1	Lysophosphatidylcholines (Lysophosphatidylcholine)IBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Interleukin-13IBA 01/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2021
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2021
1	Therapeutic UsesIBA 01/2020
1	asparaginylendopeptidase (legumain)IBA 01/2020
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 11/2019
1	BuffersIBA 01/2019
1	DefensinsIBA 12/2018
1	Protease Inhibitors (Protease Inhibitor)IBA 12/2018
1	Pancreatic Elastase (Elastase)IBA 12/2018
1	Complement System Proteins (Complement)IBA 12/2018
1	3C Viral ProteasesIBA 01/2018
1	Viral ProteasesIBA 01/2018
1	Mucosa-Associated Lymphoid Tissue Lymphoma Translocation 1 ProteinIBA 11/2015
1	Small Interfering RNA (siRNA)IBA 07/2015
1	Internal Ribosome Entry SitesIBA 07/2015
1	Viral ProteinsIBA 07/2015
1	Viral RNAIBA 07/2015
1	Heterogeneous-Nuclear Ribonucleoprotein Group MIBA 07/2015
1	AntithrombinsIBA 10/2014
1	Prothrombin (Factor II)IBA 10/2014
1	VimentinIBA 04/2012
1	matrix metalloproteinase 25IBA 04/2012
1	GlycosaminoglycansIBA 02/2012
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 09/2011
1	Peptides (Polypeptides)IBA 09/2011
1	HemopexinIBA 09/2011
1	PyrimidinonesIBA 07/2011

Therapy/Procedure

2	Therapeutics 01/2022 - 12/2021
1	Immunotherapy 01/2022
1	Transplantation 01/2009